About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Announces IVDR Certification for clonoSEQ® in European Union 08-29-2024 at 7:30 AM EDT Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference 08-22-2024 at 4:03 PM EDT Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results 08-01-2024 at 4:05 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Morgan Stanley 22nd Annual Global Healthcare Conference Sep 6, 2024 at 12:20 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 1, 2024 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2024 Earnings Presentation 816.1 KB Goldman Sachs 45th Annual Global Healthcare Conference Jun 11, 2024 at 1:20 PM EDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Sep 9, 2024 10:14 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
